Ira GOLDFINE,John Kerner,Betty A. Maddux,Michael Campbell,Jack F. Youngren,Peter Kushner
申请号：
US13399031
公开号：
US20120214758A1
申请日:
2012.02.17
申请国别(地区):
US
年份:
2012
代理人:
摘要：
A method of treatment is disclosed whereby cancer cells are brought into contact with a formulation comprising an inhibitor of tyrosine kinase receptors. The formulation may be comprised of an injectable carrier and two or more tyrosine kinase receptor inhibitors which may be nordihydrogluaiaretic acid (NDGA) and doxyrubicine.
